News
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2022 Financial Results
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and third quarter 2022 financial results.
“This has been a year marked by
BILL to Acquire Finmark, a Financial Planning and Analysis Software Company
BILL (NYSE: BILL), a leader in financial automation software for small and midsize businesses (SMBs), today announced it has signed a definitive agreement to acquire Finmark, a leading financial
Align Technology and Desktop Metal Announce Strategic Collaboration to Make iTero Element™ Flex the Preferred Restorative Intraoral Scanner for Desktop Labs’ Customers Serving General Dentists
Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners
Upland Software Reports Third Quarter 2022 Financial Results
Upland Software, Inc. (Nasdaq: UPLD), a leader in cloud-based tools for digital transformation, today announced financial and operating results for the third quarter 2022 and issued guidance for
Polaris Declares Regular Cash Dividend
Polaris Inc. (NYSE: PII) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.64 per share payable on December 15, 2022 to shareholders of record at the
Skyworks Reports Q4 and Full Year FY22 Results
Skyworks Solutions, Inc. (Nasdaq: SWKS), an innovator of high-performance analog and mixed signal semiconductors connecting people, places and things, today reported fourth fiscal quarter and
Cushman & Wakefield Reports Financial Results for the Third Quarter 2022
Cushman & Wakefield (NYSE: CWK) today reported financial results for the third quarter of 2022:
Year-to-Date Results:
-
Revenue of $7.5 billion and service line fee revenue of $5.4 billion for
VICI Properties Inc. Announces Public Offering of Common Stock
VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”), an experiential asset real estate investment trust, today announced it has commenced an underwritten public offering of
Atlassian Announces First Quarter Fiscal Year 2023 Results
Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, today announced financial results for its first quarter of fiscal year 2023 ended September
Cognex Increases Quarterly Cash Dividend
Cognex Corporation (NASDAQ: CGNX) today announced that the company's Board of Directors declared a quarterly cash dividend of $0.07 per share, payable on December 2, 2022 to all shareholders of
Origin Materials, Inc. Reports Financial Results for Third Quarter 2022
Origin Materials, Inc. (“Origin,” “Origin Materials,” or the “Company”) (Nasdaq: ORGN, ORGNW), the world’s leading carbon negative materials company with a mission to enable the world’s transition
Connection (CNXN) Reports Third Quarter 2022 Results
Connection (PC Connection, Inc.; NASDAQ: CNXN), a leading information technology solutions provider to business, government, healthcare and education markets, today announced results for the third
MedinCell’s Partner Teva Today Announced Refiling for Approval of mdc-IRM and Confirmed Planned Launch in the U.S. in H1 2023
MedinCell’s (Paris:MEDCL) partner, Teva, today announced that it recently completed the re-submission to a New Drug Application to the U.S. FDA for mdc-IRM, a risperidone subcutaneous Long-Acting
Nutrien Declares Quarterly Dividend of US$0.48 per Share
Nutrien Ltd (TSX and NYSE: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.48 per share payable on January 13, 2023, to shareholders of record on December
EQS-Adhoc: 11880 Solutions AG announces preliminary Q3 results and adjusts annual forecast
Cryptology’s estimated NAV per share as of 02/11/2022 is €4.92
Acadia Healthcare to Participate in Credit Suisse 31st Annual Healthcare Conference
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Credit Suisse 31st Annual Healthcare Conference, November 7 - 10, 2022, at Terranea Resort in
PhosAgro PJSC: PhosAgro Reports Operating and Financial Results for 9M 2022
Fuller, Smith & Turner PLC: Transaction in Own Shares
PhosAgro PJSC: PhosAgro’s Board of Directors Notes Significant Progress in Implementing the Company’s Climate Strategy
Rights and Issues Investment Trust PLC: Transaction in Own Shares
EQS-Adhoc: Progress-Werk Oberkirch AG: PWO reports figures for the first 9 months of 2022 and raises forecasts for the current fiscal year
EQS-Adhoc: JOST Werke AG: JOST raises guidance for fiscal year 2022 and publishes preliminary interim results for the first nine months of 2022
PAO Severstal: ANNOUNCEMENT OF CONSENT SOLICITATION RESULTS
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
Pfizer Inc. (NYSE:PFE) today announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the